0001225208-24-007005.txt : 20240626
0001225208-24-007005.hdr.sgml : 20240626
20240626170709
ACCESSION NUMBER: 0001225208-24-007005
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240624
FILED AS OF DATE: 20240626
DATE AS OF CHANGE: 20240626
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Evanko Brian C
CENTRAL INDEX KEY: 0001722909
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38769
FILM NUMBER: 241074441
MAIL ADDRESS:
STREET 1: 1601 CHESTNUT STREET
STREET 2: SHAREHOLDER SERVICES TL05Y
CITY: PHILADELPHIA
STATE: PA
ZIP: 19192
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cigna Group
CENTRAL INDEX KEY: 0001739940
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
ORGANIZATION NAME: 02 Finance
IRS NUMBER: 824991898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 COTTAGE GROVE ROAD
CITY: BLOOMFIELD
STATE: CT
ZIP: 06002
BUSINESS PHONE: 8602266000
MAIL ADDRESS:
STREET 1: 900 COTTAGE GROVE ROAD
CITY: BLOOMFIELD
STATE: CT
ZIP: 06002
FORMER COMPANY:
FORMER CONFORMED NAME: Cigna Corp
DATE OF NAME CHANGE: 20181221
FORMER COMPANY:
FORMER CONFORMED NAME: Halfmoon Parent, Inc.
DATE OF NAME CHANGE: 20180508
4
1
doc4.xml
X0508
4
2024-06-24
0001739940
Cigna Group
CI
0001722909
Evanko Brian C
900 COTTAGE GROVE ROAD
BLOOMFIELD
CT
06002
1
See Remarks
1
Common Stock, $.01 Par Value
2024-06-24
4
M
0
4795.0000
120.8950
A
44718.0000
D
Common Stock, $.01 Par Value
2024-06-24
4
S
0
4795.0000
345.0058
D
39923.0000
D
Common Stock, $.01 Par Value
2024-06-25
4
M
0
1011.0000
120.8950
A
40934.0000
D
Common Stock, $.01 Par Value
883.1588
I
By 401(k)
Employee Stock Option (Right to Buy)
120.8950
2024-06-24
4
M
0
4795.0000
0.0000
D
2016-02-25
2025-02-25
Common Stock, $.01 Par Value
4795.0000
1011.0000
D
Employee Stock Option (Right to Buy)
120.8950
2024-06-25
4
M
0
1011.0000
0.0000
D
2016-02-25
2025-02-25
Common Stock, $.01 Par Value
1011.0000
0.0000
D
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 15, 2024.
Represents the weighted average price of the shares sold. The prices actually received ranged from $345.00 to $345.07 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
This option was granted on February 25, 2015. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.
EVP, Chief Financial Officer and President & CEO, Cigna Healthcare
Matthew Arnold, attorney-in-fact
2024-06-25